Botulinum toxin in the management of cerebral palsy

被引:27
作者
Jefferson, RJ [1 ]
机构
[1] Battle Hosp, Dingley Child Dev Ctr, Reading RG30 1AG, Berks, England
关键词
D O I
10.1017/S0012162204000817
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:491 / 499
页数:9
相关论文
共 51 条
[1]  
ADEHALL RA, 2004, COCHRANE LIBR ISSUE
[2]   Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study [J].
Baker, R ;
Jasinski, M ;
Maciag-Tymecka, I ;
Michalowska-Mrozek, J ;
Bonikowski, M ;
Carr, L ;
MacLean, J ;
Lin, JP ;
Lynch, B ;
Theologis, T ;
Wendorff, J ;
Eunson, P ;
Cosgrove, A .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (10) :666-675
[3]   Safety profile and efficacy of botulinum toxin A (Dysporta) in children with muscle spasticity [J].
Bakheit, AMO ;
Severa, S ;
Cosgrove, A ;
Morton, R ;
Rousso, SH ;
Doderlein, L ;
Lin, JP .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (04) :234-238
[4]   Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial [J].
Barwood, S ;
Baillieu, C ;
Boyd, R ;
Brereton, K ;
Low, J ;
Nattrass, G ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (02) :116-121
[5]   Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy [J].
Boyd, RN ;
Pliatsios, V ;
Starr, R ;
Wolfe, R ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (01) :32-41
[6]   Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy [J].
Boyd, RN ;
Graham, JEA ;
Nattrass, GR ;
Graham, HK .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S37-S45
[7]  
BOYD RN, 1997, EUROPEAN J NEUROLO S, V4, P15
[8]  
Boyd Roslyn, 2000, Developmental Medicine and Child Neurology, V42, P7
[9]  
Brin MF, 1997, EUR J NEUROL, V4, pS59
[10]  
BRIN MF, 1997, MUSCLE NERVE S, V6, P146